No Data
Mino Biotech: 2024 Annual Report
Mino Biotech: Report for the first quarter of 2025
Mino Biotech: 2024 Annual Report Summary
Mei Nong Biological (301156.SZ): In the first quarter, the Net income was 8.8834 million yuan, a decrease of 7.31% year-on-year.
Gelonghui, April 25, reports that Meino Biological (301156.SZ) has announced its Q1 2025 report, achieving revenue of 99.8525 million yuan, a year-on-year increase of 1.99%; net income attributable to shareholders of the listed company is 8.8834 million yuan, a year-on-year decrease of 7.31%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses is 8.4946 million yuan, a year-on-year decrease of 5.40%; basic EPS is 0.0628 yuan.
There's Reason For Concern Over Shanghai Menon Animal Nutrition Technology Co., Ltd.'s (SZSE:301156) Massive 35% Price Jump
The "breeding heat" has led to an increase in piglet prices, listed pig companies are increasing piglet sales, and pasture companies are emerging丨Industry dynamics.
① Recently, the price of piglets has risen for three consecutive weeks, leading listed pig enterprises to increase piglet sales; ② Currently, breeding sows are being concentrated in listed pig enterprises and group pig enterprises, while smallholders mainly focus on piglet fattening and secondary fattening, and free-range farming companies are on the rise.
Shanghai Menon Animal Nutrition Technology Co., Ltd. (SZSE:301156) Shares Fly 29% But Investors Aren't Buying For Growth
